Collins James J. 4
4 · Fulcrum Therapeutics, Inc. · Filed Jun 11, 2021
Insider Transaction Report
Form 4
Collins James J.
Director
Transactions
- Award
Stock Option (right to buy)
2021-06-09+15,000→ 15,000 totalExercise: $8.85Exp: 2031-06-08→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]This option was granted on June 9, 2021 and is scheduled to vest with respect to all shares on the first anniversary of the grant date or, if earlier, immediately prior to the first annual meeting of stockholders occurring after the grant date, subject to continued service.